Thrombosis Research
Volume 124, Issue 6 , Pages 663-666, December 2009

Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS)

  • Nazim Isma

      Affiliations

    • University of Lund, Centre for Thrombosis and Haemostasis, SE – 20502 Malmö, Sweden
    • Corresponding Author InformationCorresponding author. Malmö Centre for Thrombosis and Haemostasis, Malmö University Hospital, SE – 20502 Malmö, Sweden. Tel.: +46 40331000.
  • ,
  • Peter J. Svensson

      Affiliations

    • University of Lund, Centre for Thrombosis and Haemostasis, SE – 20502 Malmö, Sweden
  • ,
  • Anders Gottsäter

      Affiliations

    • University of Lund, Vascular Centre, Malmö University Hospital, SE – 20502 Malmö, Sweden
  • ,
  • Bengt Lindblad

      Affiliations

    • University of Lund, Vascular Centre, Malmö University Hospital, SE – 20502 Malmö, Sweden

Received 2 March 2009; received in revised form 28 April 2009; accepted 30 April 2009.

Abstract 

Background

Despite venous thromboembolism (VTE) being a major cause of morbidity and mortality, there is still limited information on its prevalence and incidence in the general population.

Objective

To evaluate risk factors, distribution and epidemiology of VTE in the Malmö area with 280 000 inhabitants.

Methods

Patients diagnosed with VTE at Malmö University Hospital in 1998–2006 were invited to a prospective population-based study. Blood sampling and a questionnaire study could be performed in 70% of patients. Remaining 30% were excluded due to language problems, dementia, other severe disease, or unwillingness to participate.

Results

During 1998–2006 1140 VTE patients (559 men [49%, age 62±16 years] and 581 women [51%, age 61±20 years]) were included. Deep venous thrombosis (DVT) occurred in 882 (77%), pulmonary embolism (PE) in 330 (29%), and both DVT and PE in 72 (6%). The most common acquired risk factors among VTE patients were hormone therapy (24% of female DVT patients and 19% of female PE patients), immobilisation (17% of DVT patients and 18% of PE patients), previous surgery (13% of DVT patients and 19% of PE patients), and concomitant malignant disease (12% of DVT patients and 11% of PE patients). A positive family history for VTE was obtained from 25% of DVT patients and 22% of PE patients.

Yearly incidences of VTE, DVT and PE in Malmö were 66, 51, and 19/100.000, respectively.

Conclusion

Hormone therapy, immobilisation, previous surgery and concomitant malignancy were the most common acquired risk factors among VTE patients in this population-based study. The VTE-incidence was lower than in earlier epidemiological studies.

Keywords: VTE, Epidemiology, Incidence/Prevalence

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0049-3848(09)00215-1

doi:10.1016/j.thromres.2009.04.022

Thrombosis Research
Volume 124, Issue 6 , Pages 663-666, December 2009